Propranolol for treatment of ulcerated infantile hemangiomas

Background Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH. Objective To evaluate our experience of propranolol in the management of ulcerated IH. Methods A national, multicenter, retrospe...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Dermatology Vol. 64; no. 5; pp. 827 - 832
Main Authors Saint-Jean, Mélanie, MD, Léauté-Labrèze, Christine, MD, Mazereeuw-Hautier, Juliette, MD, Bodak, Nathalie, MD, Hamel-Teillac, Dominique, MD, Kupfer-Bessaguet, Ingrid, MD, Lacour, Jean-Philippe, MD, Naouri, Michaël, MD, Vabres, Pierre, MD, Hadj-Rabia, Smail, MD, Nguyen, Jean-Michel, MD, Stalder, Jean-François, MD, Barbarot, Sébastien, MD
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.05.2011
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH. Objective To evaluate our experience of propranolol in the management of ulcerated IH. Methods A national, multicenter, retrospective, observational study was conducted. Data were collected from the medical charts of patients treated from 2008 to 2009 and supplemented by information obtained from parents during targeted telephone interviews. Results Thirty-three infants with propranolol-treated ulcerated IH were included. The average time to complete ulceration healing was 4.3 weeks in 30 of 33 patients and was significantly faster for head-and-neck locations ( P  = .0354). The mean time to complete pain control was 14.5 days. Parents rated treatment as very effective for 27 of 31 patients and very well tolerated for 29 of 31 cases. Limitations This was a retrospective uncontrolled study. Conclusion Propranolol appears to be an effective and well-tolerated treatment for ulcerated IH.
AbstractList Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH. To evaluate our experience of propranolol in the management of ulcerated IH. A national, multicenter, retrospective, observational study was conducted. Data were collected from the medical charts of patients treated from 2008 to 2009 and supplemented by information obtained from parents during targeted telephone interviews. Thirty-three infants with propranolol-treated ulcerated IH were included. The average time to complete ulceration healing was 4.3 weeks in 30 of 33 patients and was significantly faster for head-and-neck locations (P = .0354). The mean time to complete pain control was 14.5 days. Parents rated treatment as very effective for 27 of 31 patients and very well tolerated for 29 of 31 cases. This was a retrospective uncontrolled study. Propranolol appears to be an effective and well-tolerated treatment for ulcerated IH.
Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH. To evaluate our experience of propranolol in the management of ulcerated IH. A national, multicenter, retrospective, observational study was conducted. Data were collected from the medical charts of patients treated from 2008 to 2009 and supplemented by information obtained from parents during targeted telephone interviews. Thirty-three infants with propranolol-treated ulcerated IH were included. The average time to complete ulceration healing was 4.3 weeks in 30 of 33 patients and was significantly faster for head-and-neck locations ( P = .0354). The mean time to complete pain control was 14.5 days. Parents rated treatment as very effective for 27 of 31 patients and very well tolerated for 29 of 31 cases. This was a retrospective uncontrolled study. Propranolol appears to be an effective and well-tolerated treatment for ulcerated IH.
Background Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH. Objective To evaluate our experience of propranolol in the management of ulcerated IH. Methods A national, multicenter, retrospective, observational study was conducted. Data were collected from the medical charts of patients treated from 2008 to 2009 and supplemented by information obtained from parents during targeted telephone interviews. Results Thirty-three infants with propranolol-treated ulcerated IH were included. The average time to complete ulceration healing was 4.3 weeks in 30 of 33 patients and was significantly faster for head-and-neck locations ( P  = .0354). The mean time to complete pain control was 14.5 days. Parents rated treatment as very effective for 27 of 31 patients and very well tolerated for 29 of 31 cases. Limitations This was a retrospective uncontrolled study. Conclusion Propranolol appears to be an effective and well-tolerated treatment for ulcerated IH.
BACKGROUNDUlcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for IH.OBJECTIVETo evaluate our experience of propranolol in the management of ulcerated IH.METHODSA national, multicenter, retrospective, observational study was conducted. Data were collected from the medical charts of patients treated from 2008 to 2009 and supplemented by information obtained from parents during targeted telephone interviews.RESULTSThirty-three infants with propranolol-treated ulcerated IH were included. The average time to complete ulceration healing was 4.3 weeks in 30 of 33 patients and was significantly faster for head-and-neck locations (P = .0354). The mean time to complete pain control was 14.5 days. Parents rated treatment as very effective for 27 of 31 patients and very well tolerated for 29 of 31 cases.LIMITATIONSThis was a retrospective uncontrolled study.CONCLUSIONPropranolol appears to be an effective and well-tolerated treatment for ulcerated IH.
Author Naouri, Michaël, MD
Stalder, Jean-François, MD
Bodak, Nathalie, MD
Lacour, Jean-Philippe, MD
Léauté-Labrèze, Christine, MD
Hadj-Rabia, Smail, MD
Vabres, Pierre, MD
Nguyen, Jean-Michel, MD
Hamel-Teillac, Dominique, MD
Barbarot, Sébastien, MD
Saint-Jean, Mélanie, MD
Kupfer-Bessaguet, Ingrid, MD
Mazereeuw-Hautier, Juliette, MD
Author_xml – sequence: 1
  fullname: Saint-Jean, Mélanie, MD
– sequence: 2
  fullname: Léauté-Labrèze, Christine, MD
– sequence: 3
  fullname: Mazereeuw-Hautier, Juliette, MD
– sequence: 4
  fullname: Bodak, Nathalie, MD
– sequence: 5
  fullname: Hamel-Teillac, Dominique, MD
– sequence: 6
  fullname: Kupfer-Bessaguet, Ingrid, MD
– sequence: 7
  fullname: Lacour, Jean-Philippe, MD
– sequence: 8
  fullname: Naouri, Michaël, MD
– sequence: 9
  fullname: Vabres, Pierre, MD
– sequence: 10
  fullname: Hadj-Rabia, Smail, MD
– sequence: 11
  fullname: Nguyen, Jean-Michel, MD
– sequence: 12
  fullname: Stalder, Jean-François, MD
– sequence: 13
  fullname: Barbarot, Sébastien, MD
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=24117933$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21353332$$D View this record in MEDLINE/PubMed
BookMark eNp9kU2LFDEQhoOsuLOjf8CD9EX21GM-utMdWIRl8WNhQUE9h5p0RdOmkzHpXth_b5oZFTzsqSA8b6XqqQtyFmJAQl4yumOUyTfjbgQYdpyuD3xHG_qEbBhVXS27vjsjG8oUrZXk_Jxc5DxSSlUjumfknDPRCiH4hlx9TvGQIEQffWVjquaEME8Y5iraavEGE8w4VC5YCLPzWP3ACcJ3FyfIz8lTCz7ji1Pdkm_v3329-Vjfffpwe3N9V5umoXMNA3TKqBYE7xur9kx1fUNND7Q1rbEc2g4oDkxYyWTbcyEaUNKowbac9XYvtuTy2PeQ4q8F86wnlw16DwHjknUvuSzLUVZIfiRNijkntPqQ3ATpQTOqV2l61Ks0vUrTjOsirYRendov-wmHv5E_lgrw-gRANuBt8WVc_sc1jHWqkFtydeSwyLh3mHQ2DoPBwSU0sx6ie3yOt__FjXfBlR9_4gPmMS4pFM2a6VwC-st63vW6jK27y178Bq5UoBc
CODEN JAADDB
CitedBy_id crossref_primary_10_1007_s13312_013_0098_9
crossref_primary_10_1007_s00112_011_2428_0
crossref_primary_10_1016_j_coms_2023_09_003
crossref_primary_10_1056_NEJMoa1404710
crossref_primary_10_1111_j_1525_1470_2011_01615_x
crossref_primary_10_1111_pde_15444
crossref_primary_10_1007_s13671_012_0026_6
crossref_primary_10_1016_j_jaad_2014_01_905
crossref_primary_10_1111_j_1468_3083_2011_04105_x
crossref_primary_10_1111_bjd_14687
crossref_primary_10_25259_CSDM_257_2023
crossref_primary_10_7759_cureus_16683
crossref_primary_10_1097_GOX_0000000000000605
crossref_primary_10_1542_peds_2015_2485
crossref_primary_10_1016_j_ad_2012_03_010
crossref_primary_10_1111_pde_13372
crossref_primary_10_1007_s00247_016_3643_6
crossref_primary_10_1016_j_anpedi_2015_04_007
crossref_primary_10_1007_s00247_017_4042_3
crossref_primary_10_1007_s10006_015_0528_z
crossref_primary_10_1016_j_arcped_2015_01_001
crossref_primary_10_1016_j_coms_2023_09_010
crossref_primary_10_1371_journal_pone_0138100
crossref_primary_10_1111_j_1600_0560_2012_01913_x
crossref_primary_10_1097_JDN_0000000000000645
crossref_primary_10_1007_s12519_013_0427_z
crossref_primary_10_1111_j_1529_8019_2012_01481_x
crossref_primary_10_1111_pde_12089
crossref_primary_10_1016_j_clindermatol_2014_02_002
crossref_primary_10_1016_S0151_9638_11_70098_9
crossref_primary_10_1111_bjd_12436
crossref_primary_10_1111_1346_8138_15189
crossref_primary_10_1016_j_bjoms_2016_02_031
crossref_primary_10_1016_j_jpeds_2016_04_069
crossref_primary_10_1177_1203475418770570
crossref_primary_10_1007_s11604_019_00885_5
crossref_primary_10_1016_j_adengl_2012_01_015
crossref_primary_10_1016_j_adengl_2012_03_020
crossref_primary_10_1016_j_arcped_2013_03_020
crossref_primary_10_1097_SAP_0000000000003206
crossref_primary_10_1016_j_jmv_2014_06_001
crossref_primary_10_3389_fped_2023_1073090
crossref_primary_10_1007_s12519_018_0137_7
crossref_primary_10_1111_pde_12869
crossref_primary_10_3928_00904481_20120727_10
crossref_primary_10_1053_j_semperi_2012_11_003
crossref_primary_10_1002_jcu_22471
crossref_primary_10_1542_neo_16_1_e16
crossref_primary_10_1542_peds_2016_0353
crossref_primary_10_11131_2014_101041
crossref_primary_10_1016_j_therap_2020_02_007
crossref_primary_10_1016_j_jaad_2013_03_002
crossref_primary_10_1016_S1761_2896_18_88284_X
crossref_primary_10_1002_hed_24308
crossref_primary_10_1016_S0140_6736_16_00645_0
crossref_primary_10_1111_jpc_12600
crossref_primary_10_1016_j_anpede_2015_10_014
crossref_primary_10_1016_j_pharma_2014_03_001
crossref_primary_10_1001_jamadermatol_2021_0469
crossref_primary_10_1016_j_pepo_2012_11_009
crossref_primary_10_1002_med_21984
crossref_primary_10_1007_s10103_012_1220_2
crossref_primary_10_1542_peds_2012_1691
crossref_primary_10_1111_j_1365_2230_2012_04397_x
crossref_primary_10_1007_s40272_013_0008_6
crossref_primary_10_1016_j_bjps_2013_07_035
crossref_primary_10_1016_j_pcl_2013_11_010
crossref_primary_10_1016_j_ad_2011_05_003
crossref_primary_10_1016_j_lfs_2014_02_007
crossref_primary_10_2310_7750_2012_12037
crossref_primary_10_1016_S1245_1789_15_70116_2
crossref_primary_10_1111_bjd_12417
crossref_primary_10_1111_ped_14077
Cites_doi 10.1111/j.1525-1470.2008.00781_2.x
10.1016/j.jpeds.2007.04.055
10.1001/archderm.140.8.963
10.1111/j.1365-2133.2010.09848.x
10.1001/archderm.136.5.628
10.1001/archderm.138.12.1567
10.1067/mjd.2001.112382
10.1684/ejd.2008.0576
10.1542/peds.2008-3458
10.1056/NEJMc0708819
ContentType Journal Article
Copyright American Academy of Dermatology, Inc.
2011 American Academy of Dermatology, Inc.
2015 INIST-CNRS
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
Copyright_xml – notice: American Academy of Dermatology, Inc.
– notice: 2011 American Academy of Dermatology, Inc.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
CorporateAuthor Groupe de Recherche Clinique en Dermatologie Pédiatrique
CorporateAuthor_xml – name: Groupe de Recherche Clinique en Dermatologie Pédiatrique
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.jaad.2010.12.040
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6787
EndPage 832
ExternalDocumentID 10_1016_j_jaad_2010_12_040
21353332
24117933
S0190962211000168
1_s2_0_S0190962211000168
Genre Multicenter Study
Journal Article
GroupedDBID ---
--K
--M
-RU
.1-
.FO
.GJ
.XZ
.~1
0R~
1B1
1CY
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
6PF
7-5
71M
8F7
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQQT
AAQXK
AAWTL
AAXKI
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABXDB
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
ADVLN
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFFNX
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
C45
CAG
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEA
HMK
HMO
HVGLF
HX~
HZ~
IHE
J1W
J5H
KOM
LZ2
M27
M41
MO0
N9A
O-L
O9-
OAUVE
OB.
OBH
OHH
OM~
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SAE
SDF
SDG
SDP
SEL
SES
SJN
SPCBC
SSH
SSZ
T5K
TEORI
UHS
UNMZH
UV1
WOW
WUQ
Y6R
YFH
Z5R
ZCG
ZGI
ZY1
~G-
AAIAV
ABLVK
ABYKQ
AJBFU
EFLBG
LCYCR
08R
ABPIF
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
ACRPL
ADNMO
CITATION
7X8
ID FETCH-LOGICAL-c440t-ada79c95a3284f9b197840c8a05c5cf2a57a0ed13f616582334a96c9df5218fb3
IEDL.DBID AIKHN
ISSN 0190-9622
IngestDate Fri Oct 25 00:48:40 EDT 2024
Fri Dec 06 04:43:44 EST 2024
Sat Sep 28 07:50:55 EDT 2024
Sun Oct 22 16:06:55 EDT 2023
Fri Feb 23 02:33:24 EST 2024
Tue Oct 15 22:54:59 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords ulceration
FPDL
flashlamp pulsed-dye laser (therapy)
infantile hemangioma
propranolol
IH
Human
Vascular disease
Angioma
Treatment
Dermatology
Cardiovascular disease
Antiarrhythmic agent
Propranolol
Ulceration
Child
Language English
License CC BY 4.0
Copyright © 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c440t-ada79c95a3284f9b197840c8a05c5cf2a57a0ed13f616582334a96c9df5218fb3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 21353332
PQID 862600001
PQPubID 23479
PageCount 6
ParticipantIDs proquest_miscellaneous_862600001
crossref_primary_10_1016_j_jaad_2010_12_040
pubmed_primary_21353332
pascalfrancis_primary_24117933
elsevier_sciencedirect_doi_10_1016_j_jaad_2010_12_040
elsevier_clinicalkeyesjournals_1_s2_0_S0190962211000168
PublicationCentury 2000
PublicationDate 2011-05-01
PublicationDateYYYYMMDD 2011-05-01
PublicationDate_xml – month: 05
  year: 2011
  text: 2011-05-01
  day: 01
PublicationDecade 2010
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
PublicationTitle Journal of the American Academy of Dermatology
PublicationTitleAlternate J Am Acad Dermatol
PublicationYear 2011
Publisher Mosby, Inc
Elsevier
Publisher_xml – name: Mosby, Inc
– name: Elsevier
References Chiller, Passaro, Frieden (bib6) 2002; 138
Chamlin, Haggstrom, Drolet, Baselga, Frieden, Garzon (bib9) 2007; 151
Sans, Dumas de la Roque, Berge, Grenier, Boralevi, Mazereeuw-Hautier (bib5) 2009; 124
Léauté-Labrèze, Dumas de la Roque, Hubiche, Boralevi, Thambo, Taïeb (bib4) 2008; 358
Morelli, Tan, Weston (bib12) 1991; 145
George, Sharma, Jacobson, Simon, Nopper (bib3) 2004; 140
Storch, Hoeger (bib7) 2010; 163
Kim, Colombo, Frieden (bib1) 2001; 44
Hermans, Boezeman, Van de Kerkhof, Rieu, Van der Vleuten (bib10) 2009; 19
Poetke, Philipp, Berlien (bib11) 2000; 136
Yan (bib2) 2008; 25
Mohammadi, Bakhshaeekia, Alibeigi, Hasheminasab, Tolide-ei, Tavakkolian (bib8) 2009; 30
Mohammadi (10.1016/j.jaad.2010.12.040_bib8) 2009; 30
Chamlin (10.1016/j.jaad.2010.12.040_bib9) 2007; 151
Poetke (10.1016/j.jaad.2010.12.040_bib11) 2000; 136
Kim (10.1016/j.jaad.2010.12.040_bib1) 2001; 44
Sans (10.1016/j.jaad.2010.12.040_bib5) 2009; 124
Chiller (10.1016/j.jaad.2010.12.040_bib6) 2002; 138
George (10.1016/j.jaad.2010.12.040_bib3) 2004; 140
Hermans (10.1016/j.jaad.2010.12.040_bib10) 2009; 19
Yan (10.1016/j.jaad.2010.12.040_bib2) 2008; 25
Storch (10.1016/j.jaad.2010.12.040_bib7) 2010; 163
Léauté-Labrèze (10.1016/j.jaad.2010.12.040_bib4) 2008; 358
Morelli (10.1016/j.jaad.2010.12.040_bib12) 1991; 145
References_xml – volume: 44
  start-page: 962
  year: 2001
  end-page: 972
  ident: bib1
  article-title: Ulcerated hemangiomas: clinical characteristics and response to therapy
  publication-title: J Am Acad Dermatol
  contributor:
    fullname: Frieden
– volume: 140
  start-page: 963
  year: 2004
  end-page: 969
  ident: bib3
  article-title: Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas
  publication-title: Arch Dermatol
  contributor:
    fullname: Nopper
– volume: 124
  start-page: 423
  year: 2009
  end-page: 431
  ident: bib5
  article-title: Propranolol for severe infantile hemangiomas: follow-up report
  publication-title: Pediatrics
  contributor:
    fullname: Mazereeuw-Hautier
– volume: 30
  start-page: 1013
  year: 2009
  end-page: 1017
  ident: bib8
  article-title: Efficacy of propranolol in wound healing for hospitalized burn patients
  publication-title: J Burn Care Res
  contributor:
    fullname: Tavakkolian
– volume: 358
  start-page: 2649
  year: 2008
  end-page: 2651
  ident: bib4
  article-title: Propranolol for severe hemangiomas of infancy
  publication-title: N Engl J Med
  contributor:
    fullname: Taïeb
– volume: 136
  start-page: 628
  year: 2000
  end-page: 632
  ident: bib11
  article-title: Flashlamp-pumped pulsed dye laser for hemangiomas in infancy
  publication-title: Arch Dermatol
  contributor:
    fullname: Berlien
– volume: 25
  start-page: 586
  year: 2008
  end-page: 589
  ident: bib2
  article-title: Pain management for ulcerated hemangiomas
  publication-title: Pediatr Dermatol
  contributor:
    fullname: Yan
– volume: 145
  start-page: 1062
  year: 1991
  end-page: 1064
  ident: bib12
  article-title: Treatment of ulcerated hemangiomas with the pulsed tunable dye laser
  publication-title: Am J Dis Child
  contributor:
    fullname: Weston
– volume: 138
  start-page: 1567
  year: 2002
  end-page: 1576
  ident: bib6
  article-title: Hemangiomas of infancy: clinical characteristics, morphologic subtypes and their relationship to race, ethnicity and sex
  publication-title: Arch Dermatol
  contributor:
    fullname: Frieden
– volume: 163
  start-page: 269
  year: 2010
  end-page: 274
  ident: bib7
  article-title: Propranolol for infantile hemangiomas: insights into the molecular mechanisms of action
  publication-title: Br J Dermatol
  contributor:
    fullname: Hoeger
– volume: 151
  start-page: 684
  year: 2007
  end-page: 689
  ident: bib9
  article-title: Multicenter prospective study of ulcerated hemangiomas
  publication-title: J Pediatr
  contributor:
    fullname: Garzon
– volume: 19
  start-page: 152
  year: 2009
  end-page: 156
  ident: bib10
  article-title: Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases
  publication-title: Eur J Dermatol
  contributor:
    fullname: Van der Vleuten
– volume: 25
  start-page: 586
  year: 2008
  ident: 10.1016/j.jaad.2010.12.040_bib2
  article-title: Pain management for ulcerated hemangiomas
  publication-title: Pediatr Dermatol
  doi: 10.1111/j.1525-1470.2008.00781_2.x
  contributor:
    fullname: Yan
– volume: 151
  start-page: 684
  year: 2007
  ident: 10.1016/j.jaad.2010.12.040_bib9
  article-title: Multicenter prospective study of ulcerated hemangiomas
  publication-title: J Pediatr
  doi: 10.1016/j.jpeds.2007.04.055
  contributor:
    fullname: Chamlin
– volume: 145
  start-page: 1062
  year: 1991
  ident: 10.1016/j.jaad.2010.12.040_bib12
  article-title: Treatment of ulcerated hemangiomas with the pulsed tunable dye laser
  publication-title: Am J Dis Child
  contributor:
    fullname: Morelli
– volume: 140
  start-page: 963
  year: 2004
  ident: 10.1016/j.jaad.2010.12.040_bib3
  article-title: Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.140.8.963
  contributor:
    fullname: George
– volume: 163
  start-page: 269
  year: 2010
  ident: 10.1016/j.jaad.2010.12.040_bib7
  article-title: Propranolol for infantile hemangiomas: insights into the molecular mechanisms of action
  publication-title: Br J Dermatol
  doi: 10.1111/j.1365-2133.2010.09848.x
  contributor:
    fullname: Storch
– volume: 136
  start-page: 628
  year: 2000
  ident: 10.1016/j.jaad.2010.12.040_bib11
  article-title: Flashlamp-pumped pulsed dye laser for hemangiomas in infancy
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.136.5.628
  contributor:
    fullname: Poetke
– volume: 138
  start-page: 1567
  year: 2002
  ident: 10.1016/j.jaad.2010.12.040_bib6
  article-title: Hemangiomas of infancy: clinical characteristics, morphologic subtypes and their relationship to race, ethnicity and sex
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.138.12.1567
  contributor:
    fullname: Chiller
– volume: 30
  start-page: 1013
  year: 2009
  ident: 10.1016/j.jaad.2010.12.040_bib8
  article-title: Efficacy of propranolol in wound healing for hospitalized burn patients
  publication-title: J Burn Care Res
  contributor:
    fullname: Mohammadi
– volume: 44
  start-page: 962
  year: 2001
  ident: 10.1016/j.jaad.2010.12.040_bib1
  article-title: Ulcerated hemangiomas: clinical characteristics and response to therapy
  publication-title: J Am Acad Dermatol
  doi: 10.1067/mjd.2001.112382
  contributor:
    fullname: Kim
– volume: 19
  start-page: 152
  year: 2009
  ident: 10.1016/j.jaad.2010.12.040_bib10
  article-title: Differences between ulcerated and non-ulcerated hemangiomas, a retrospective study of 465 cases
  publication-title: Eur J Dermatol
  doi: 10.1684/ejd.2008.0576
  contributor:
    fullname: Hermans
– volume: 124
  start-page: 423
  year: 2009
  ident: 10.1016/j.jaad.2010.12.040_bib5
  article-title: Propranolol for severe infantile hemangiomas: follow-up report
  publication-title: Pediatrics
  doi: 10.1542/peds.2008-3458
  contributor:
    fullname: Sans
– volume: 358
  start-page: 2649
  year: 2008
  ident: 10.1016/j.jaad.2010.12.040_bib4
  article-title: Propranolol for severe hemangiomas of infancy
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc0708819
  contributor:
    fullname: Léauté-Labrèze
SSID ssj0009437
Score 2.3692315
Snippet Background Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel...
Ulcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel treatment for...
BACKGROUNDUlcerated infantile hemangiomas (IH) are a therapeutic challenge. Propranolol, a nonselective beta-blocker, was recently introduced as a novel...
SourceID proquest
crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 827
SubjectTerms Adrenergic beta-Antagonists - administration & dosage
Adrenergic beta-Antagonists - therapeutic use
Biological and medical sciences
Child
Child, Preschool
Dermatology
Female
General aspects
Head and Neck Neoplasms - drug therapy
Hemangioma - complications
Hemangioma - drug therapy
Hemangioma - pathology
Humans
infantile hemangioma
Male
Medical sciences
propranolol
Propranolol - administration & dosage
Propranolol - therapeutic use
Retrospective Studies
Skin Neoplasms - drug therapy
Skin Ulcer - drug therapy
Skin Ulcer - etiology
Treatment Outcome
ulceration
Wound Healing - drug effects
Title Propranolol for treatment of ulcerated infantile hemangiomas
URI https://www.clinicalkey.es/playcontent/1-s2.0-S0190962211000168
https://dx.doi.org/10.1016/j.jaad.2010.12.040
https://www.ncbi.nlm.nih.gov/pubmed/21353332
https://search.proquest.com/docview/862600001
Volume 64
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7ygFIope86bRcdeivuWpbstaCXEBq2LQ2FNpCbGOtRNgTvEu9e-9szs5Y3hD4OvRrLFt-MZj5J30gAb1FiodARc8NQ5No0PjdKF3kTSmLbTgXvt2qLs3p-rj9fVBd7cDLWwrCsMsX-IaZvo3V6Mk1oTleLxfQ7V0GbuuQZDBOXZh8OKR3xXu3h8acv87Pbs3e12lVNc4NUOzPIvC4R_aDw4lVBXgP5c356sMKeUIvDdRd_56PbvHT6CB4mQimOhz4_hr3QPYF7X9OW-VP48O16uaLPUZC7EsRQxU5aLpZRbK4cn6ocvCBPI5ApRgg-xrX7uWDh0DM4P_3442SepysTcqd1sc7R48w4U6GitBNNK2mSqAvXYFG5ysUSqxkWwUsVa0nco1RKo6md8ZHSeBNb9RwOumUXXoIwZSuVrGPTBKlbX3Mqw0phY-qWeEzM4N0IlF0NJ2PYUTJ2aRlWy7BaWVqCNYPZiKUdaz4pSoU-DZneStvTm_Y3s2ZQ7Vre8QxLQf-ff5zcMdmuk-wkFJVUBmK0oaUxxRsl2IXlprfbWR7_PYMXg21vG_M9IUqVR__Zq1dwf1iVZsnkazhYX2_CG6I163YC--9_yUly3hsi2_N8
link.rule.ids 314,780,784,4502,24116,27924,27925,45585,45679
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgESQrwJlOIDNxQ2jp1sLHFBVasF2gqJVurNmvhRbVVlV83uld_OTB5bVRQOvUZ2bH1jz3y2v7EBPqLETKEj5oYhS7WpfGqUztIq5MS2nQred2qL43J2qr-fFWdbsDfmwrCscvD9vU_vvPXwZTKgOVnO55NfnAVtypxXMExcqntwXxfEfmlQf_59rfMwWm1yprn4kDnTi7wuEH2v7-I9Qd4BuT06PV5iS5jF_rGLf7PRLiodPIUnA50UX_seP4Ot0DyHB0fDgfkL-PLzarGk35GLuxTET8VGWC4WUawvHd-pHLygcUYQk4cQfIlrcz5n2dBLOD3YP9mbpcODCanTOlul6HFqnClQUdCJppa0RNSZqzArXOFijsUUs-CliqUk5pErpdGUzvhIQbyKtXoF282iCW9AmLyWSpaxqoLUtS85kGGhsDJlTSwmJvBpBMou-3sx7CgYu7AMq2VYrcwtwZrAdMTSjhmf5KNCO0yY1krbUkn7l1ETKDY1b4wLSy7_vy3u3jDZppPEWNgnqQTEaENLM4qPSbAJi3VruzUet57A696215X5lRCl8rd37NUHeDg7OTq0h9-Of7yDR_3-NIsnd2B7dbUO74ngrOrdbgD_AVOU9FU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Propranolol+for+treatment+of+ulcerated+infantile+hemangiomas&rft.jtitle=Journal+of+the+American+Academy+of+Dermatology&rft.au=Saint-Jean%2C+M%C3%A9lanie&rft.au=L%C3%A9aut%C3%A9-Labr%C3%A8ze%2C+Christine&rft.au=Mazereeuw-Hautier%2C+Juliette&rft.au=Bodak%2C+Nathalie&rft.date=2011-05-01&rft.issn=0190-9622&rft.volume=64&rft.issue=5&rft.spage=827&rft.epage=832&rft_id=info:doi/10.1016%2Fj.jaad.2010.12.040&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jaad_2010_12_040
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01909622%2FS0190962211X00063%2Fcov150h.gif